[go: up one dir, main page]

CN111675672A - Method for preparing astallurens - Google Patents

Method for preparing astallurens Download PDF

Info

Publication number
CN111675672A
CN111675672A CN202010397868.5A CN202010397868A CN111675672A CN 111675672 A CN111675672 A CN 111675672A CN 202010397868 A CN202010397868 A CN 202010397868A CN 111675672 A CN111675672 A CN 111675672A
Authority
CN
China
Prior art keywords
methyl
preparing
benzoate
fluorophenyl
oxadiazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010397868.5A
Other languages
Chinese (zh)
Inventor
方瑜
杜玉民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shijiazhuang Duzhi Pharmaceutical Technology Co ltd
Original Assignee
Shijiazhuang Duzhi Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shijiazhuang Duzhi Pharmaceutical Technology Co ltd filed Critical Shijiazhuang Duzhi Pharmaceutical Technology Co ltd
Priority to CN202010397868.5A priority Critical patent/CN111675672A/en
Publication of CN111675672A publication Critical patent/CN111675672A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention discloses a method for preparing atraurone (Ataluren, PTC124, trade name Translarna), belonging to the field of organic synthesis. Methyl m-cyanobenzoate and hydroxylamine hydrochloride react in lower alcohol or a mixed solvent of the lower alcohol and water to generate 3- (N-hydroxyamidino) -methyl benzoate; o-acylation reaction of methyl 3- (N-hydroxycarbamimidoyl) -benzoate and O-fluorobenzoyl chloride in organic solvent to obtain methyl 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoate; carrying out cyclization under the catalytic action of tetraalkylammonium halide to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate; fourthly, hydrolyzing to obtain the atractylen. The invention is a simple and high-efficiency synthesis method of the astallurens.

Description

Method for preparing astallurens
Technical Field
The invention relates to a method for preparing atraumatic, belonging to the field of organic synthesis.
Background
Attulellan, english name: ataluren, trade name: (Translarna), chemical name: 3- ((5- (2-fluorophenyl)) - (1,2, 4-oxadiazol-3-yl)) -benzoic acid. Is a small molecule oral drug developed by PTC in the united states for the treatment of nonsense-mutated Duchenne muscular dystrophy (Duchenne and Becker) and cystic fibrosis, and is currently marketed in europe and in phase iii in the united states. During translation of mRNA, ribosomes are allowed to pass over the stop codon that appears prematurely in the mRNA, allowing normal genetic information to be read and the synthesis of a fully functional protein. The structure of astallurone is as follows:
Figure 799511DEST_PATH_IMAGE001
in the prior art, the methyl m-cyanobenzoate is generally reacted with hydroxylamine hydrochloride to produce the methyl 3- (N-hydroxyamidino) -benzoate. The ester is subjected to O-acylation reaction with O-fluorobenzoyl chloride to obtain 3- (N- (2-fluorobenzoyloxy) amidino) -methyl benzoate, and cyclization is carried out to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate. Hydrolyzing under alkaline condition to obtain the alpha-gulen.
The method for synthesizing the atraumatic in the patent CN101535284A comprises the following steps: the method comprises the steps of adopting a one-pot method to prepare alpha-methyl cyanobenzoate as an initial raw material, carrying out a reaction with hydroxylamine hydrochloride, carrying out an O-acylation reaction on O-fluorobenzoyl chloride, cyclizing to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate, and hydrolyzing under an acidic condition to obtain alpha-lulan. The reaction time was about 63 hours, with 32 hours for the cyclization reaction to proceed, and the overall yield was 67%. The reaction time is long, the intermediate is not separated, and impurities in the final product are complex.
WO2004091502A/US6992096 is similar to CN101535284A, but the reaction is carried out step by step, O-acylation and cyclization are carried out on O-fluorobenzoyl chloride by taking toluene as a solvent, a water separation device is arranged, reflux is carried out for 4 hours at 130 ℃, and then stirring is carried out for 18 hours at 5 ℃.
Laura Lentini, Raffaella Melfi, Aldo Di Leonardo et al published in molecular pharmaceuticals (2014, 11, 653-664) introduced the synthesis of Altaluron by using 3-cyanobenzoyl chloride as raw material, esterification, acylation-cyclization, and catalytic hydrolysis of boron trifluoride as solvent to obtain Altaluron with a total yield of 40%.
There are generally two methods by which the basic parent 1,2, 4-oxadiazole in the molecular structure of arabinls can be obtained. Firstly, the 1, 3-dipolar cycloaddition between cyano group of nitrile compound and cyano oxide is difficult to obtain raw material, the specificity of reaction is poor, and the product is complex. Another method is the cyclization of aminooxime derivatives. Aminooxime derivatives are readily prepared by reacting a cyano group with hydroxylamine followed by acylation with carboxylic acids and their derivatives. Therefore, the latter method is often used for the synthesis of astallurens.
The existing synthetic technical route of the atralon is analyzed, so that the amino oxime derivative synthesized in the first step and the second step is relatively mature reaction, and the yield is relatively high. The cyclization reaction is the technical key of the whole synthesis process. The reaction type of the step belongs to nucleophilic addition-elimination reaction, the reaction speed is low, the efficiency is low along with the rise of the reaction temperature and the extension of the reaction time, the purification is not easy, and the side products generated by cyclization with the amino oxime are increased, so that the yield and the purity of the final product are influenced. The invention adopts the catalyst to catalyze and make the cyclization reaction of the amidoxime O-acylated derivative easy to carry out.
Disclosure of Invention
The invention aims to solve the technical problem of providing a method for preparing the atraumatic, and the invention is a simple and efficient atraumatic synthesis method.
The technical scheme adopted by the invention is as follows: a method of preparing artoluron, comprising the steps of:
(1) adding methyl m-cyanobenzoate and hydroxylamine hydrochloride into a low molecular alcohol or a low molecular alcohol aqueous solution, and reacting in the presence of alkali to generate 3- (N-hydroxyamidino) -methyl benzoate;
Figure DEST_PATH_IMAGE002
(2) putting the ester obtained in the step (1) and O-fluorobenzoyl chloride into an organic solvent for O-acylation reaction to obtain 3- (N- (2-fluorobenzoyloxy) amidino) -methyl benzoate;
Figure DEST_PATH_IMAGE003
(3) cyclizing the ester obtained in the step (2) under the action of a quaternary ammonium salt catalyst to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate;
Figure DEST_PATH_IMAGE004
(4) hydrolyzing the ester obtained in the step (3) under an alkaline condition to obtain the aliskiren.
Figure DEST_PATH_IMAGE005
Preferred catalysts are quaternary ammonium salts of the formula R4N+X-R is C1-C16In chain hydrocarbon radicals
And X is one of Cl, Br, I or F.
The preferred catalyst is one of quaternary ammonium salts tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium iodide or tetrabutylammonium fluoride.
The preferred catalyst is the quaternary ammonium salt tetrabutylammonium fluoride.
The preferred lower alcohol is one of methanol, ethanol or isopropanol.
The preferable molar ratio of the catalyst to the methyl m-cyanobenzoate is 0.05-1: 1.
In a preferable mixed solvent of lower alcohol and water, the ratio of alcohol to water is 10-1: 1.
The preferred base is one of sodium carbonate, potassium carbonate, sodium hydroxide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide, triethylamine or diisopropylethylamine.
The preferable organic solvent is one of dichloromethane, tetrahydrofuran, dimethylformamide, acetonitrile, ethylene glycol dimethyl ether or acetone.
In the preparation process of the important intermediate 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate of the alpha-toluron, methyl m-cyanobenzoate is used as a raw material to react with hydroxylamine hydrochloride to generate the methyl 3- (N-hydroxyamidino) -benzoate. Followed by O-acylation with O-fluorobenzoyl chloride to give methyl 3- (N- (2-fluorobenzoyloxy) amidino) -benzoate. At room temperature, the methyl 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoate is obtained through catalytic cyclization. Hydrolyzing under alkaline condition to obtain the alpha-gulen.
The synthetic route is as follows:
Figure DEST_PATH_IMAGE006
adopt the produced beneficial effect of above-mentioned technical scheme to lie in: the method is simple and efficient, and can obviously shorten the reaction time on the premise of ensuring the product yield. The total yield of the preparation method of the atractylen can reach 68%, and the purity of the prepared atractylen can reach more than 99.0% after once crystallization.
The specific implementation mode is as follows:
preparation of methyl 3- (N-hydroxycarbamimidoyl) -benzoate
(1) Methyl m-cyanobenzoate (80.1 g, 0.5 mol) in ethanol (800 mL) was added hydroxylamine hydrochloride (68.5 g, 1.0 mol) and sodium ethoxide (68.05 g, 1.0 mol). The reaction was stirred at room temperature for 20 h and the solvent was evaporated under reduced pressure. Ethyl acetate (500 mL) was added to the residue, which was filtered and evaporated under reduced pressure to give a crude product, which was slurried with water, filtered and dried to give 92.5 g of methyl 3- (N-hydroxycarbamimidoyl) -benzoate as a white solid with a yield of 95% and mp.101-102.1 ℃. MS (M/z): 195[ M + H]+
1H-NMR(400 MHz,DMSO-d 6 ): 9.83 (s,1H),8.41 (d,1H;J= 0.9 Hz),8.01(t,1H;J= 7.5 Hz),7.56 (t,1H;J= 7.5 Hz),6.02 (s,2H),3.95 (s,3H)。
(2) Methyl m-cyanobenzoate (12 g, 74.4 mmol) was dissolved in methanol (240 mL), and hydroxylamine hydrochloride (12.8 g, 186 mmol) was added with stirring. A solution of sodium methoxide (11.8 g, 186 mmol) in methanol (240 mL) was added dropwise to the reaction mixture, the mixture was reacted at room temperature for 20 hours, methanol was distilled off under reduced pressure, ethyl acetate (300 mL) was added, the mixture was filtered, and ethyl acetate was distilled off under reduced pressure to obtain a crude product, which was slurried with water, filtered, and dried to obtain methyl 3- (N-hydroxycarbamimidoyl) -benzoate as a white solid in a yield of 87%.
(3) Hydroxylamine hydrochloride (32.1 g, 0.468 mol) and sodium carbonate (32.6 g, 0.31 mol) were added to a solution of methyl m-cyanobenzoate (50.0 g, 0.31 mol) in ethanol (500 mL), stirred at room temperature, water (200 mL) was added, and stirring was continued for 16 h. The reaction mixture was poured into 500mL of ice water, filtered to give the crude product, which was recrystallized from ethyl acetate-N-hexane to give methyl 3- (N-hydroxycarbamimidoyl) -benzoate as a white solid, 43.95g, 73%.
Preparation of methyl 3- (N-2-fluorobenzoyloxyamidyl) benzoate
(1) 3- (N-hydroxycarbamimidoyl) -benzoic acid methyl ester (120 g, 620 mmol) is dissolved in anhydrous tetrahydrofuran (400 mL), diisopropylethylamine (150 mL, 868 mmol) is added, 2-fluorobenzoyl chloride (96.2 mL, 806 mmol) is added dropwise at 5 deg.C, the mixture is stirred at room temperature for 1h, filtered, concentrated under reduced pressure, the residue is dissolved in ethyl acetate (800 mL), washed with water (250 mL × 3), dried over anhydrous sodium sulfate, the solvent is evaporated under reduced pressure and recrystallized from ethyl acetate and N-hexane (6: 4) to give a white solid, 3- (N-2-fluorobenzoyloxyamidino) benzoic acid methyl ester 175g, 89.2%.1H-NMR(400 MHz,CDCl3): 8.18(1H),8.03(2H),7.48(2H),7.18(2H),5.61(2H),3.82(3H)。
(2) Methyl 3- (N-hydroxycarbamimidoyl) -benzoate (10 g, 51.5 mmol) was dissolved in acetone (180 mL), stirred at room temperature, potassium carbonate (8.55 g, 61.87 mmol) and o-fluorobenzoyl chloride (9.81 g, 61.87 mmol) were added, stirred at room temperature for 1h, and acetone was evaporated under reduced pressure. The residue was dissolved in ethyl acetate (80 mL), washed with water (25 mL. times.3), dried over anhydrous sodium sulfate, the solvent was evaporated under reduced pressure, and the residue was recrystallized from ethyl acetate and N-hexane (6: 4) to give a white solid, methyl 3- (N-2-fluorobenzoyloxyamidino) benzoate 14 g, 86.2%.
Preparation of fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate
Methyl 3- (N-2-fluorobenzoyloxyamidyl) benzoate (63.5g, 0.2 mol) was dissolved in THF (500 mL) and tetrabutylammonium fluoride (1 mol/L in THF, 20 mL, 0.02 mol) was added dropwise at room temperature and stirred for 24 h. The mixture was poured into ethyl acetate, and washed with water and saturated brine, respectively. Drying with anhydrous sodium sulfate, decompressing to obtain a solvent, and recrystallizing with ethyl acetate-n-hexane to obtain 54.28g of white solid 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate and 91 percent. mp.133.8-136.4 ℃. MS (M/z) 299[ M + H ] +.
1H-NMR (400 MHz,DMSO-d 6): 8.78 (t,1H,J= 1.8 Hz),8.31 (dt,1H,J 1=7.8 Hz,J 2= 1.4 Hz),8.18−8.12 (m,2H),7.59−7.52 (m,2H),7.32−7.20 (m,2H),3.91(s,3H)。
Preparation of fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoic acid
Methyl 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoate (80 g, 0.268 mol) was added to a tetrahydrofuran-water (2: 1) mixed solvent (800 mL), lithium hydroxide (38.5 g) was added, the mixture was stirred at room temperature for 24 hours, the solvent was evaporated under reduced pressure, water was added for dilution, acidification was performed with hydrochloric acid to precipitate a white precipitate, and filtration and drying were performed to obtain 63.8 g, 88% of 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoic acid as a white solid. mp.239.5-241.6 ℃. And (3) HPLC detection result: chemical purity of 99.8%, SunFereTMC18Chromatography column (150 mm × 4.6.6 mm, 5 μ M) with mobile phase of acetonitrile-0.1% formic acid (50: 50), MS (M/z): 285[ M + H]+。1H-NMR (400 MHz,DMSO-d 6) : 7.51(t,2H,Ar,J= 8.9 Hz),7.56(d,2H,Ar,J= 8.8Hz),8.07(m,1H,Ar),8.17-8.34 (d,2H,Ar,J= 8.9Hz),8.68 (s,1H,Ar),13.36 (brs,1 H,OH)。

Claims (9)

1. A method for preparing atraulon, which is characterized by comprising the following steps:
(1) adding methyl m-cyanobenzoate and hydroxylamine hydrochloride into lower alcohol or a mixed solvent of the lower alcohol and water, and reacting under an alkaline condition to generate methyl 3- (N-hydroxycarbamimidoyl) -benzoate;
(2) dissolving the methyl 3- (N-hydroxycarbamimidoyl) -benzoate obtained in the step (1) and o-fluorobenzoyl chloride in an organic solvent
Carrying out O-acylation reaction in a medium to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate;
(3) under the catalytic action of tetraalkylammonium halide, 3- ((5- (2-fluorophenyl)) -3- (1,2,4-
Oxadiazolyl)) -benzoic acid methyl ester;
(4) 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate are hydrolyzed to obtain the aliskiren.
2. The process for preparing arturin according to claim 1, characterized in that said tetrahydrocarbon is
Based on the formula of the ammonium halide catalyst R4N+X-R is C1~C16One or more than two kinds of chain alkyl, X is one of Cl, Br, I or F.
3. The method for preparing attulellan according to claim 2, wherein the quaternary ammonium salt catalyst is one of tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium iodide or tetrabutylammonium fluoride.
4. The method for preparing attulellan according to claim 3, wherein the quaternary ammonium salt catalyst is tetrabutylammonium fluoride.
5. The method for preparing aliskiren according to claim 1, wherein the lower alcohol is one of methanol, ethanol, or isopropanol.
6. The method for preparing atralone according to claim 1, wherein the molar ratio of the catalyst to the methyl m-cyanobenzoate is 0.05-1: 1.
7. The method for preparing arturin according to claim 1, wherein the lower alcohol is water
The ratio of the alcohol to the water in the mixed solvent of (1) to (10).
8. A process according to claim 1, wherein the base used is an alkali
Sodium carbonate, potassium carbonate, sodium hydroxide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide, triethylamine
Or diisopropylethylamine.
9. A process for preparing aliskiren according to claim 1, wherein the organic solvent used is
The medium is one of dichloromethane, tetrahydrofuran, dimethylformamide, acetonitrile, ethylene glycol dimethyl ether or acetone.
CN202010397868.5A 2020-05-12 2020-05-12 Method for preparing astallurens Pending CN111675672A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010397868.5A CN111675672A (en) 2020-05-12 2020-05-12 Method for preparing astallurens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010397868.5A CN111675672A (en) 2020-05-12 2020-05-12 Method for preparing astallurens

Publications (1)

Publication Number Publication Date
CN111675672A true CN111675672A (en) 2020-09-18

Family

ID=72452443

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010397868.5A Pending CN111675672A (en) 2020-05-12 2020-05-12 Method for preparing astallurens

Country Status (1)

Country Link
CN (1) CN111675672A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045510A (en) * 2021-03-31 2021-06-29 北京大学生命科学华东产业研究院 Preparation method of astallurens
CN114920667A (en) * 2022-06-30 2022-08-19 湖南大学 A kind of electrochemical preparation method of ataluron ester

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204461A1 (en) * 2003-04-11 2004-10-14 Karp Gary Mitchell 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
CN104428296A (en) * 2012-07-02 2015-03-18 孟山都技术公司 Process for preparing 3,5-disubstituted-1,2,4-oxadiazoles
CN105461650A (en) * 2014-09-12 2016-04-06 杭州普晒医药科技有限公司 Oxdiazole compound solvate and preparation method thereof
WO2016073545A1 (en) * 2014-11-06 2016-05-12 Concert Pharmaceuticals, Inc. Phenyloxadiazole benzoic acids
CN106279057A (en) * 2016-08-15 2017-01-04 东莞明日医药有限公司 The novel synthesis of Ataluren
TW201808922A (en) * 2016-06-20 2018-03-16 台灣神隆股份有限公司 Process for preparing ataluren and its intermediates

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204461A1 (en) * 2003-04-11 2004-10-14 Karp Gary Mitchell 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
CN104428296A (en) * 2012-07-02 2015-03-18 孟山都技术公司 Process for preparing 3,5-disubstituted-1,2,4-oxadiazoles
CN105461650A (en) * 2014-09-12 2016-04-06 杭州普晒医药科技有限公司 Oxdiazole compound solvate and preparation method thereof
WO2016073545A1 (en) * 2014-11-06 2016-05-12 Concert Pharmaceuticals, Inc. Phenyloxadiazole benzoic acids
TW201808922A (en) * 2016-06-20 2018-03-16 台灣神隆股份有限公司 Process for preparing ataluren and its intermediates
CN106279057A (en) * 2016-08-15 2017-01-04 东莞明日医药有限公司 The novel synthesis of Ataluren

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANTHONY R. GANGLOFF,ET AL.: "Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst", 《TETRAHEDRON LETTERS》 *
DOUGLAS S. AULD,ET AL.: "Mechanism of PTC124 activity in cell-based lucifierase assays of nonsense codon suppression", 《PNAS》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045510A (en) * 2021-03-31 2021-06-29 北京大学生命科学华东产业研究院 Preparation method of astallurens
CN113045510B (en) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 Preparation method of atralone
CN114920667A (en) * 2022-06-30 2022-08-19 湖南大学 A kind of electrochemical preparation method of ataluron ester

Similar Documents

Publication Publication Date Title
US20070149522A1 (en) Method for producing 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
US20070105921A1 (en) Process for Preparing Oxazole Intermediates
RU2711358C1 (en) Simple method of producing avibactam
CN109640657B (en) Process for preparing 4-alkoxy-3- (acyl or aliphatic saturated hydrocarbyl) oxypyridine carboxamides
CN111675672A (en) Method for preparing astallurens
CN114478690B (en) Preparation method of 6, 6-dimethyl-3-azabicyclo [3.1.0] hexane derivative
CN112645833A (en) Synthesis method of (S) -2, 6-diamino-5-oxohexanoic acid
WO2011026318A1 (en) S-5-substituent-n-2'-(thiophene-2-yl)ethyl-tetralin-2-amine or chiral acid salts thereof and use for preparing rotigotine
CN102911160A (en) Method for preparing and purifying dabigatran etexilate intermediate
JP2018090551A (en) L-carnosine derivative or salt thereof, and method for producing L-carnosine or salt thereof
CN113527137A (en) Preparation method of characteristic impurities of trifloxystrobin
WO2016115962A1 (en) Preparation method for nebivolol intermediate and preparation method for nebivolol
CN101506141A (en) 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester and method for producing the same
CN115433140A (en) Synthetic method of Aforana
CN110878097B (en) Preparation method of feigninib
CN103450066B (en) The preparation method of Telaprevir intermediate
CN113264875A (en) Synthesis method of flonicamid
KR100564072B1 (en) Method for non-pressurely preparing α, α-dimethylphenylacetic acid from α, α-dimethylbenzyl cyanide
JP2001302658A (en) Method for manufacturing of 3-isochromanones
CN115819260B (en) Synthesis process of sitagliptin intermediate
CN113372235B (en) Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids
JP2021526142A (en) Process for preparing 2- (1- (tert-butoxycarbonyl) piperidine-4-yl) benzoic acid
JPS5927343B2 (en) Synthesis method of 3-aminoisoxazoles
JP2001502298A (en) Methods and new intermediates
JP4368494B2 (en) Method for producing carboxylic acid tertiary alkyl ester

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200918

WD01 Invention patent application deemed withdrawn after publication